Lv3
328 积分 2024-10-23 加入
Cyclin-dependent protein kinase inhibitors including palbociclib as anticancer drugs
8天前
已完结
Cdk1 is sufficient to drive the mammalian cell cycle
8天前
已完结
PROactively TACkling CDK4/6 therapy resistance
8天前
已完结
CDK4/6 Inhibition in Cancer: Beyond Cell Cycle Arrest
8天前
已完结
Treating cancer with selective CDK4/6 inhibitors
8天前
已完结
MONARCH 3: Abemaciclib As Initial Therapy for Advanced Breast Cancer
8天前
已完结
Bortezomib plus rituximab alone in patients with relapsed, rituximab-naive or rituximab-sensitive, follicular lymphoma: a randomised phase 3 Trial
8天前
已完结
Cell cycle, CDKs and cancer: a changing paradigm
8天前
已完结
Hallmarks of Cancer: The Next Generation
8天前
已完结
Consensus molecular subtypes and the evolution of precision medicine in colorectal cancer
8天前
已完结
皖公网安备34019202002308
